Minimally Invasive Treatments of the Thyroid (MIPA-MITT)

European Institute of Oncology

Status

Enrolling

Conditions

Papillary Thyroid Microcarcinoma

Treatments

Procedure: image-guided thermal ablation

Study type

Observational

Funder types

Other

Identifiers

NCT06333587

IEO 1810

Details and patient eligibility

About

This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Thyroid MicroCarcinoma (PTMC)

Full description

Image-guided thermal ablations have been successfully applied in the treatment of several type of tumors, and have been recently proposed as a potential alternative to surgery also in patients with thyroid diseases, and named "Minimally Invasive Treatments of the Thyroid (MITT)". These minimally invasive treatments, compared to surgical treatment have similar efficacy, fewer complications, better quality of life, and better cosmetic outcomes. These procedures allow precise delivery of the heat locally to the lesion, sparing the surrounding thyroid tissue, and thus minimizing the invasiveness of the treatment and the impact on thyroid function.

This study aim to establish a prospective registry of the cases of patients treated with MITT for a Papillary Thyroid MicroCarcinoma (PTMC), in order to validate the safety of the procedure and to set the basis for collecting long term results in a large cohort of patients.

Enrollment

270 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients > 18years
Patients with diagnosis of papillary thyroid microcarcinoma, citologically proven, suitable for MITT.
Written informed consent must be signed and dated by the patient and the investigator prior to inclusion.
Patients must be accessible for follow-up

Exclusion criteria

Tumors > 1 cm, other citological type, refusal of MITT, unsuitable for MITT, unmanageable coagulative disorders
Patients with psychiatric, addictive, or any disorder, which compromises ability to give informed consent for participation in this study